IP Verse

Curevac competitive analysis

Latest oppositions filed by Curevac

Explore patent oppositions filed by Curevac against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2528626
Influenza Nucleic Acid Molecules And Vaccines Made TherefromTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJun 23, 2017

Latest patents of Curevac opposed by its competitors

Explore Curevac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4227319
Nov 26, 2025Novel Rsv Rna Molecules And Compositions For Vaccination1
EP3090060
May 21, 2025Methods For Rna Analysis2
EP3283059
Jan 3, 2024Method For Producing Rna Compositions8
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna Molecule4
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration8
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP1881847
Jan 11, 2023Injection Solution For Rna2
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna Production3
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3283125
Dec 29, 2021Lyophilization Of Rna2

Latest PTAB cases involving Curevac

Discover the latest PTAB cases involving Curevac, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 31, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Curevac

IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision
IPR2017-02194Sep 29, 2017MODERNATXCUREVACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Curevac with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CUREVAC180 - 1
ETHERNA IMMUNOTHERAPIES12 - - -
STRAWMAN468 - - -
WEINZIERL, GERHARD13 - - -